{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:03:09Z","timestamp":1792008189277,"version":"4.4.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lymphoma is the most common malignancy affecting cats. A protocol employing vincristine, l-asparaginase, cyclophosphamide, doxorubicin, and prednisone (VELCAP-S) is effective and well tolerated in dogs with lymphoma. A 24-week variation of this protocol (VELCAP-C) was developed for treatment of cats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>That VELCAP-C will result in survival times for cats with lymphoma that are similar to those obtained when cats are treated with a protocol that includes fewer chemotherapy agents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Sixty-one cats with lymphoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective study. Outcomes evaluated were response to VELCAP-C therapy, toxicosis, and survival time. The effect of signalment, staging, CBC, and serum chemistry profile and dosage on these outcomes was examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Six cats (10%) completed the protocol with a median survival of 1189 days. Forty-three percent (23 of 61) of the cats achieved complete response (CR) with a median survival time of 62 days. Cats that required a dose reduction of any drug during induction were more likely to achieve CR. Weight loss and hepatomegaly at diagnosis were negatively associated with response to treatment. Increased lactate dehydrogenase (LDH) serum activity at the time of initial treatment correlated with decreased survival times.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>This multi agent protocol did not provide improved survival over historical data using protocols with fewer agents. Serum LDH activity levels might provide useful prognostic information for cats with lymphoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1939-1676.2007.0031.x","type":"journal-article","created":{"date-parts":[[2008,12,11]],"date-time":"2008-12-11T15:41:44Z","timestamp":1229010104000},"page":"153-157","source":"Crossref","is-referenced-by-count":37,"title":["Efficacy and Toxicosis of VELCAP-C Treatment of Lymphoma in Cats"],"prefix":"10.1093","volume":"22","author":[{"given":"A.G.","family":"Hadden","sequence":"first","affiliation":[{"name":"Tufts University Cummings School of Veterinary Medicine , Grafton, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Cotter","sequence":"additional","affiliation":[{"name":"Tufts University Cummings School of Veterinary Medicine , Grafton, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Rand","sequence":"additional","affiliation":[{"name":"Tufts University Cummings School of Veterinary Medicine , Grafton, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Moore","sequence":"additional","affiliation":[{"name":"Tufts University Cummings School of Veterinary Medicine , Grafton, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Davis","sequence":"additional","affiliation":[{"name":"Ashland Animal Center , Ashland, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Morrissey","sequence":"additional","affiliation":[{"name":"Tufts University Cummings School of Veterinary Medicine , Grafton, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,1,1]]},"reference":[{"key":"2026020304153698000_b1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1292\/jvms1939.36.163","article-title":"Pathological observations of natural cases of feline lymphosarcomatosis","volume":"36","author":"Takahshi","year":"1974","journal-title":"Jap J Vet Sci"},{"key":"2026020304153698000_b2","first-page":"349","article-title":"Feline lymphoma (145 cases)","volume":"12","author":"Vail","year":"1998","journal-title":"Proliferative indices, cluster of differentiation 3 immunoreactivity, and their association with prognosis in 90 cats"},{"key":"2026020304153698000_b3","author":"Maudlin"},{"key":"2026020304153698000_b4","first-page":"696","article-title":"Treatment and prognostic factors in lymphoma in cats","volume":"194","author":"Mooney","year":"1989","journal-title":"104 cases (1977\u20131981)"},{"key":"2026020304153698000_b5","first-page":"179","article-title":"Chemotherapy with cyclophosphamide, vincristine, and prednisolone (COP) in cats with malignant lymphoma","volume":"16","author":"Teske","year":"2002","journal-title":"New results with an old protocol"},{"key":"2026020304153698000_b6","first-page":"1118","article-title":"Response rates and survival times for cats with lymphoma treated with the University of Wisconsin-Madison chemotherapy protocol","volume":"227","author":"Milner","year":"2005","journal-title":"38 cases (1996\u20132003)"},{"key":"2026020304153698000_b7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1751-0813.1998.tb12300.x","article-title":"Clinical and anatomical features of lymphosarcoma in 118 cats","volume":"76","author":"Gabor","year":"1998","journal-title":"Aus Vet J"},{"key":"2026020304153698000_b8","first-page":"512","article-title":"Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs","volume":"210","author":"Valerius","year":"1997","journal-title":"121 cases (1987\u20131995)"},{"key":"2026020304153698000_b9","first-page":"315","article-title":"Comparison of two protocols for the induction of remission in dogs with lymphoma","volume":"27","author":"Stone","year":"1991","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020304153698000_b10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1939-1676.1997.tb00476.x","article-title":"Evaluation of a multi-drug chemotherapy protocol (ACOPA\u2013II) for treatment of dogs with lymphoma","volume":"11","author":"Myers","year":"1997","journal-title":"J Vet Intern Med"},{"key":"2026020304153698000_b11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1939-1676.1993.tb01021.x","article-title":"Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma","volume":"7","author":"Keller","year":"1993","journal-title":"J Vet Intern Med"},{"key":"2026020304153698000_b12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1939-1676.1998.tb02151.x","article-title":"A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma","volume":"12","author":"Zemann","year":"1998","journal-title":"J Vet Intern Med"},{"key":"2026020304153698000_b13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1939-1676.2001.tb02328.x","article-title":"Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma","volume":"15","author":"Moore","year":"2001","journal-title":"J Vet Intern Med"},{"key":"2026020304153698000_b14","first-page":"1144","article-title":"Results of chemotherapy for cats with alimentary malignant lymphoma","volume":"213","author":"Zwahlen","year":"1998","journal-title":"21 cases (1993\u20131997)"},{"key":"2026020304153698000_b15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1939-1676.1999.tb02176.x","article-title":"Prognostic value of Argyrophilic Nucleolar Organizer Region (AgNOR) staining in feline intestinal lymphoma","volume":"13","author":"Rassnick","year":"1999","journal-title":"J Vet Intern Med"},{"key":"2026020304153698000_b16","first-page":"125","article-title":"Single agent chemotherapy with doxorubicin for feline lymphoma","volume":"15","author":"Kristal","year":"2001","journal-title":"A retrospective study of 19 cases (1994\u20131997)"},{"key":"2026020304153698000_b17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1939-1676.1996.tb02083.x","article-title":"A comparison of doxorubicin and COP for maintenance of remission in cats with lymphoma","volume":"10","author":"Moore","year":"1996","journal-title":"J Vet Intern Med"},{"key":"2026020304153698000_b18","first-page":"1593","article-title":"Alimentary lymphoma in cats","volume":"207","author":"Mahony","year":"1995","journal-title":"28 cases (1988\u20131993)"},{"key":"2026020304153698000_b19","first-page":"166","article-title":"Treatment of lymphoma and leukemia with cyclophosphamide, vincristine, and prednisone","volume":"19","author":"Cotter","year":"1983","journal-title":"II. Treatment of cats"},{"key":"2026020304153698000_b20","volume-title":"Textbook of Veterinary Internal Medicine","author":"Ettinger","year":"2000","edition":"5th ed"},{"key":"2026020304153698000_b21","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/ajcp\/78.5.712","article-title":"Serum total and isoenzyme lactate dehydrogenase activity in American Burkitt's lymphoma patients","volume":"78","author":"Csako","year":"1982","journal-title":"Am J Clin Pathol"},{"key":"2026020304153698000_b22","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1200\/JCO.1989.7.10.1518","article-title":"A new serologic staging system for large-cell lymphomas based in initial \u00df2-microglobulin and lactate dehydrogenase levels","volume":"7","author":"Swan","year":"1989","journal-title":"J of Clin Oncol"},{"key":"2026020304153698000_b23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1939-1676.1997.tb00066.x","article-title":"Correlation between serum creatine kinase activities and anorexia in cats","volume":"11","author":"Fascetti","year":"1997","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1939-1676.2007.0031.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/22\/1\/153\/66672106\/j.1939-1676.2007.0031.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/22\/1\/153\/66672106\/j.1939-1676.2007.0031.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:16:20Z","timestamp":1770110180000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/22\/1\/153\/8449831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1939-1676.2007.0031.x","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,1]]},"published":{"date-parts":[[2008,1,1]]}}}